
Eczema Could Compromise Flu Shots
Researchers suggest that patients with eczema should request that their flu shots be administered intramuscularly and not intradermally.
If you have eczema, your annual flu shot will probably be a little bit more effective if you are willing to put a little more pain into the process of getting it. According to Donald Leung, PhD, an allergist and immunologist at National Jewish Health’s Department of Pediatrics, patients with eczema should request that their flu shots be administered in their muscle in order to optimize their chances of avoiding the seasonal infection.
Dr. Leung
Eczema, also
Dr. Leung and his team evaluated immune responses to the flu shot in 202 people with eczema and 136 people without the skin condition. Half of the participants received an intradermal (below the skin) flu vaccine injection, while the other half received an intramuscular injection. Only about 11% of those individuals in the intradermal group developed protection against the flu after a month, while nearly half (47%) of the intramuscular group had. A total of 42% of the participants who had eczema also had staph skin infections.
Although Dr. Leung and his team stopped short of conclusively linking the bacterial infection and the lower flu immunization rate among patients who received that intradermal injection, they did say that prior studies indicate that staph can cause immune cells to “retreat” from the skin and become less active in general. The group emphasized that their results “highlight the need for special care when immunizing people with eczema.”
According to Nick Francis, PhD, a clinical reader at Cardiff University and co-author on a recently published
“It has been estimated that 40% of children with eczema aged five years or younger are given antibiotics in the course of a year,” Dr. Francis said, adding that he and his team “question the ongoing use of antibiotics for eczema flares” based on their recent research. The team conducted a 3-arm, blinded, randomized, controlled trial in United Kingdom ambulatory care units to evaluate whether or not children who received antibiotic treatment for mild eczema flares benefitted from the treatment. “Neither oral nor topical antibiotics produced a significant difference in mean Patient Oriented Eczema Measure (POEM) scores,” reported the group, adding, “We ruled out a clinically meaningful benefit from the addition of either oral or topical antibiotics.”
The CDC notes, “Drug allergies and intolerances are more common in people with immune deficiencies largely because they are exposed to more drugs.” However, in the case of chronic eczema sufferers and flu shots, the issue appears to revolve around the staph infection’s “dampening” of the vaccine’s efficacy.
The stakes are particularly high in the case of eczema patients with staph, though, because staph infections come with an additional flu-related complication: higher morbidity if a patient does eventually catch the flu. As early as 2008, researchers
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.